BNET Industries
Biovail Corp. is in the Pharma Industry
Latest News and Analysis
RBC Likes Biovail's Strategy Shift
FP Trading Desk submits: RBC Capital Markets analyst Doug Miehm offered qualified support for drug maker Biovail Corp.'s BVF much talked about strategic shift into central nervous system drugs, praising management in a note this morning for doing "a good job" of explaining the new focus. However, in a...
Analyst call advisory - The Concerned Shareholders of Biovail Conference Call and Web Cast for Analysts
TORONTO, June 17 /PRNewswire/ --
Biovail Concerned Shareholders Want Open Debate
Biovail CEO Refuses to Meet; Concerned Shareholders Believe It Reflects Unwillingness To Confront Issues and to Reveal His Inexperience and Lack of Industry Knowledge
Letter Challenges Biovail CEO to a Debate
TORONTO, June 16 /PRNewswire/ -- The Concerned Shareholders of Biovail Corporation (TSX: BVF) today sent the following letter to William Wells, CEO of Biovail Corporation:
New Analyst Reports for Q9 NETWORKS INC, GRIZZLY DIAMONDS LTD, BIOVAIL CORPORATION, and PARAMOUNT RESOURCES LTD
MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments Q9 NETWORKS...
Biovail Announces That RiskMetrics Group Recommends Shareholders Vote "For" Biovail's Director Nominees
RiskMetrics Notes Current Board and Management "Are Well Versed in Taking the Tough Business Decisions That Will Allocate Resources in the Most Value Enhancing Areas"
New Video Exposes Failures of Incumbent Biovail Board and Executives - Reinforces Plan for a Better Biovail
Bruce Brydon to host a Web Cast and Question and Answer Session for Analysts
The Concerned Shareholders of Biovail Say Biovail's Incumbent Board Misled ISS/RiskMetrics; Express Confidence Shareholders Will See Through Charade
The Concerned Shareholders of Biovail Say Their Experience, Track Record And Plan Reasons To Vote Yellow Proxy
Biovail Provides Update on Share Repurchase Program
TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that, as of June 12, 2008, the Company has purchased over 1,000,000 of its common shares under its previously announced share repurchase program. Open-market purchases continue under the program.
Biovail to Present at 2008 Goldman Sachs Global Healthcare Conference
TORONTO -- Biovail Corporation (NYSE:BVF) (TSX: BVF) today announced that the Company will present at the 2008 Goldman Sachs Annual Global Healthcare Conference at the Ritz-Carlton Laguna Niguel in Dana Point, California.
Concerned Shareholders Respond to Biovail
New Shareholder Letters Mailed for a Better Biovail
Biovail Shareholders Should Disregard the Latest Misinformation from Eugene Melnyk
Vote Your BLUE Proxy Now
Biovail Responds to Dissident Circular
Vote Your BLUE Proxy Now
Bruce Brydon Responds to Biovail's Misleading Statements to Shareholders
TORONTO, June 5 /PRNewswire/ -- The following is a statement from Bruce Brydon in response to Biovail's misleading letter to shareholders on June 5, 2008:
Biovail Notes Filing of Dissident Circular
TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) confirmed today that it has been advised of the filing of a dissident proxy circular by former Chairman and Chief Executive Officer CEO Eugene Melnyk, in which Mr. Melnyk proposes his own slate of nominees for election to the Board of Directors of Biovail.
Biovail Launches Normal Course Issuer Bid
TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that commencing on June 2, 2008 it may make purchases of its common shares on the open market under its previously announced normal course issuer bid NCIB.
Bernstein Litowitz and Milberg LLP Announce the Proposed Settlement of a Securities Class Action Lawsuit against Biovail Corporation and Certain of Its Officers or Directors for U.S.$138 Million in Cash
NEW YORK -- This Notice relates to the following actions:
Biovail Announces Mailing and Filing of Management Proxy Circular
Shareholders Urged to Complete the BLUE Form of Proxy in Favour of Biovail's Board Nominees
Biovail Subsidiary Reaches Settlement with United States Department of Justice
TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that a subsidiary of the Company has reached an agreement with the United States Department of Justice DOJ in respect of criminal allegations related to activities surrounding the 2003 commercial launch of Cardizem[R] LA. In particular, the allegations relate to prior management's actions...
New Analyst Reports for NORTHSTAR HEALTHCARE INC, THOMPSON CREEK METALS COMPANY INC, BIOVAIL CORPORATION, and KATANGA MINING LTD
MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments NORTHSTAR HEALTHCARE...
- Next »
- page 1 of 31
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- FDA (40 results)
- stock (18 results)
- shareholder (16 results)
- health care (14 results)
- agreement (13 results)
- financial (12 results)
- board (10 results)
- marketing (8 results)
- SEC (7 results)
- sales (6 results)
- Company (6 results)
- corporate governance (6 results)
- board of directors (5 results)
- manufacturing (5 results)
- GlaxoSmithKline Plc. (5 results)
- life science (5 results)
- FTC (5 results)
- UBS AG (5 results)
- J.P. Morgan Chase & Co. (4 results)
- physician (4 results)
- Annual (4 results)
- Aventis (4 results)
- Orange PCS (4 results)
- acquisition (4 results)
- stock market (4 results)
- tablet (4 results)
- finance (3 results)
- strategy (3 results)
- Goldman Sachs & Co. (3 results)
- pharmaceutical company (3 results)
- Verizon Communications Inc. (3 results)
- arbitration (3 results)
- litigation (3 results)
- dividend (3 results)
- R&D (3 results)
- blood pressure (3 results)
- Morgan Stanley (3 results)
- biotechnology (3 results)
Biovail Corp. Company Info
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
